Can an elevated reticulocyte (reticulocyte count) count interfere with the Glucose-6-Phosphate Dehydrogenase (G-6-PD) assay?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Reticulocyte Count and G-6-PD Assay Interference

True. An elevated reticulocyte count can interfere with the G-6-PD assay, potentially causing falsely normal results in G-6-PD deficient patients.

Mechanism of Interference

  • Reticulocytes contain significantly higher amounts of G-6-PD enzyme than mature erythrocytes 1
  • In patients with hemolytic conditions, reticulocytosis can mask underlying G-6-PD deficiency by elevating the overall measured enzyme activity 2
  • This interference is particularly problematic in:
    • Neonates with physiologic reticulocytosis
    • Patients with hemolytic anemia
    • Patients recovering from acute blood loss
    • Patients responding to treatment for anemia

Clinical Evidence

  • According to the American Society of Hematology guidelines, reticulocytosis can significantly impact G-6-PD activity measurements 1
  • In pyruvate kinase deficiency studies, researchers have observed that reticulocyte-rich blood can mask enzyme deficiencies, which applies similarly to G-6-PD testing 2
  • In G-6-PD deficient patients with high reticulocyte counts, the G-6-PD activity may fall within reference limits despite the underlying deficiency 2

Detection Strategies

To mitigate this interference and improve diagnostic accuracy:

  1. Compare enzyme ratios: Calculate the ratio of G-6-PD activity to another age-dependent enzyme (similar to PK/HK ratio approach) 2
  2. Flow cytometric assay: This method has shown better reliability in detecting G-6-PD deficiency in the presence of reticulocytosis compared to spectrophotometric methods 3
  3. Genetic testing: For definitive diagnosis in cases with suspected interference, molecular analysis for common G-6-PD mutations is recommended 4

Clinical Implications

  • Misdiagnosis of G-6-PD deficiency due to reticulocytosis can lead to:
    • Inappropriate administration of oxidative drugs
    • Unexpected hemolytic crises
    • Severe hyperbilirubinemia in neonates 2
    • Delayed appropriate management

Recent Research Findings

While the traditional understanding has been that reticulocytosis interferes with G-6-PD assays, some recent studies have challenged this view:

  • A 2022 study found that reticulocytosis did not have a statistically significant effect on the detection of G-6-PD deficiency in newborns using both qualitative and quantitative methods 5
  • However, this finding contradicts established clinical practice and earlier research, so caution is still warranted 2, 1

Best Practice Recommendations

  • When G-6-PD deficiency is suspected but test results are normal or borderline:
    • Consider the reticulocyte count when interpreting G-6-PD assay results
    • Repeat testing when reticulocyte count normalizes
    • Consider molecular testing for definitive diagnosis in critical cases
    • Use flow cytometric methods when available for more accurate assessment 3

The interference of reticulocytosis with G-6-PD assay results remains an important clinical consideration that can impact patient management and outcomes, particularly in preventing severe hemolytic episodes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.